30.04.2015 – Watson-Marlow Fluid Technology Group has acquired Asepco through its parent company Spirax-Sarco Engineering plc, for £ 7.0 million. Asepco, based in California USA, specialises in the design and manufacture of high purity aseptic valves and magnetic mixers for the bioprocessing industry. Asepco is a natural extension of the Watson-Marlow’s fluid path product portfolio and further strengthens the already strong global presence in the biotechnology and pharmaceutical industries.
There is clear synergy and a significant growth opportunity presented by bringing together the product ranges. Jay Whalen, President of the Watson-Marlow Fluid Technology Group comments: „The strategic acquisition of Asepco further broadens our product range and strengthens Watson-Marlow’s position in the biopharmaceutical market. This enables us to provide a more comprehensive and improved service to our customers looking for sterility throughout their fluid path. This is another exciting milestone for Watson-Marlow and we are looking forward to accelerating our growth within the biopharmaceutical market with our broadened product portfolio coupled to our process expertise”.
Share:
